Leeaf is conducting research in fertility to advance treatment for current IVF patients and future generations of women. In November, Leeaf CEO Olga Chabr Grillova and Head of Data Science Lucie Borovickova, will present two of Leeaf's research projects at The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI) 2023 in Vienna, Austria.
COGI is a multi-disciplinary conference focusing on latest research developments in the field of obstetrics, gynecology and infertility. The congress highlights controversial issues in women’s health and facilitates debates and discussions to fuel a knowledge exchange between speakers and attendees and bridge the gaps between expansion of basic science and information, and their consolidation into clinical practice.
The first research project to be presented by Leeaf focuses on the readiness of clinics for AI and the effect of cycle numbers and data completeness on the prediction of mature oocytes (MII). The second study is centred around research-based data collection and decision support system for controlled ovarian stimulation (COS).
“We are incredibly humbled to have received such distinguished recognition from COGI and to be given the opportunity to present our research efforts in November. At Leeaf, we are conducting one-of-a-kind research to fuel our product development and empower patients and physicians through research-backed and data-driven solutions,” states Lucie.
To participate in our studies or join our research efforts, connect with Leeaf through www.leeaf.life/contact-us
